ARGX — argenx SE stock price, charts and financials

QT62argenx SE

argenx SE (NASDAQ: ARGX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
874.17
+9.13+1.06%
OverviewShort InterestFilings
ARGXQT62argenx SE·NASDAQ
874.17+1.06%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 06, 2026SC TO-TThird-party tender offer statement
Aug 06, 2026SC TO-T/ASC TO-T/A
Aug 03, 20266-KForeign issuer report
Jul 28, 2026SC TO-CSC TO-C
Jul 27, 2026SC TO-CSC TO-C
Jul 27, 20266-KForeign issuer report
Jul 23, 20266-KForeign issuer report
Jun 23, 20266-KForeign issuer report
Jun 03, 20266-KForeign issuer report
May 11, 20266-KForeign issuer report
May 07, 20266-KForeign issuer report
May 06, 20266-KForeign issuer report
May 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 20, 20266-KForeign issuer report
Mar 20, 20266-KForeign issuer report
Mar 19, 20266-KForeign issuer report
Mar 19, 202620-FAnnual report (foreign issuers)
Mar 06, 20266-KForeign issuer report
Feb 26, 20266-KForeign issuer report
Feb 26, 20266-KForeign issuer report
Jan 13, 20266-KForeign issuer report
Jan 12, 20266-KForeign issuer report
Jan 05, 20266-KForeign issuer report
Dec 17, 2025S-8Registration of employee benefit securities
Dec 15, 20256-KForeign issuer report
#1 / 25 of 137
Page
▼
/ 6